209 related articles for article (PubMed ID: 18402598)
1. Identification of a human monoclonal Fab with neutralizing activity against H3N2 influenza A strain from a newly constructed human Fab library.
Shibuya T; Yamashiro T; Masaike Y; Ohuchi M; Uechi G; Nishizono A
Microbiol Immunol; 2008 Mar; 52(3):162-70. PubMed ID: 18402598
[TBL] [Abstract][Full Text] [Related]
2. Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition.
Yamashita A; Kawashita N; Kubota-Koketsu R; Inoue Y; Watanabe Y; Ibrahim MS; Ideno S; Yunoki M; Okuno Y; Takagi T; Yasunaga T; Ikuta K
Biochem Biophys Res Commun; 2010 Mar; 393(4):614-8. PubMed ID: 20152806
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of human neutralizing antibodies to rabies virus derived from a recombinant immune antibody library.
Houimel M; Dellagi K
J Virol Methods; 2009 Nov; 161(2):205-15. PubMed ID: 19559727
[TBL] [Abstract][Full Text] [Related]
4. Fab MAbs specific to HA of influenza virus with H5N1 neutralizing activity selected from immunized chicken phage library.
Pitaksajjakul P; Lekcharoensuk P; Upragarin N; Barbas CF; Ibrahim MS; Ikuta K; Ramasoota P
Biochem Biophys Res Commun; 2010 May; 395(4):496-501. PubMed ID: 20382115
[TBL] [Abstract][Full Text] [Related]
5. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
[TBL] [Abstract][Full Text] [Related]
6. Construction of human Fab (gamma1/kappa) library and identification of human monoclonal Fab possessing neutralizing potency against Japanese encephalitis virus.
Arakawa M; Yamashiro T; Uechi G; Tadano M; Nishizono A
Microbiol Immunol; 2007; 51(6):617-25. PubMed ID: 17579273
[TBL] [Abstract][Full Text] [Related]
7. Determination of serum neutralization antibodies against seasonal influenza A strain H3N2 and the emerging strains 2009 H1N1 and avian H5N1.
Zhang R; Rong X; Pan W; Peng T
Scand J Infect Dis; 2011 Mar; 43(3):216-20. PubMed ID: 21142624
[TBL] [Abstract][Full Text] [Related]
8. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma.
Zuccotti G; Amendola A; Viganò A; Pariani E; Zappa A; Pogliani L; Giacomet V; Savarino A; Podestà A; Rottoli A; Tanzi E; Zanetti A; Radaelli G
Vaccine; 2007 Sep; 25(37-38):6692-8. PubMed ID: 17697730
[TBL] [Abstract][Full Text] [Related]
9. Isolation of therapeutic human monoclonal antibodies for varicella-zoster virus and the effect of light chains on the neutralizing activity.
Suzuki K; Akahori Y; Asano Y; Kurosawa Y; Shiraki K
J Med Virol; 2007 Jun; 79(6):852-62. PubMed ID: 17457901
[TBL] [Abstract][Full Text] [Related]
10. [Generation of human recombinant antibody Fab fragment to influenza virus from combined antibody library].
Yang G; Han F; Liang M
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Jun; 15(2):182-5. PubMed ID: 11436656
[TBL] [Abstract][Full Text] [Related]
11. [The influenza season 2004/'05 in the Netherlands with the largest epidemic of the last 5 years caused by the virus variant A/California and the composition of the vaccine for the season 2005/'06].
de Jong JC; Rimmelzwaan GF; Bartelds AI; Meijer A; Fouchier RA; Osterhaus AD
Ned Tijdschr Geneeskd; 2005 Oct; 149(42):2355-61. PubMed ID: 16261717
[TBL] [Abstract][Full Text] [Related]
12. [The 2005-2006 influenza season in the Netherlands and the vaccine composition for the 2006-2007 season].
Rimmelzwaan GF; de Jong JC; Donker GA; Meijer A; Fouchier RA; Osterhaus AD
Ned Tijdschr Geneeskd; 2006 Oct; 150(40):2209-14. PubMed ID: 17061434
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies in man that neutralized H3N2 influenza viruses were classified into three groups with distinct strain specificity: 1968-1973, 1977-1993 and 1997-2003.
Okada J; Ohshima N; Kubota-Koketsu R; Ota S; Takase W; Azuma M; Iba Y; Nakagawa N; Yoshikawa T; Nakajima Y; Ishikawa T; Asano Y; Okuno Y; Kurosawa Y
Virology; 2010 Feb; 397(2):322-30. PubMed ID: 19969317
[TBL] [Abstract][Full Text] [Related]
14. Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma.
Safdar A; Rodriguez MA; Fayad LE; Rodriguez GH; Pro B; Wang M; Romaguera JE; Goy AH; Hagemeister FB; McLaughlin P; Bodey GP; Kwak LW; Raad II; Couch RB
J Infect Dis; 2006 Nov; 194(10):1394-7. PubMed ID: 17054068
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV).
Burioni R; Canducci F; Mancini N; Clementi N; Sassi M; De Marco D; Saita D; Diotti RA; Sautto G; Sampaolo M; Clementi M
New Microbiol; 2009 Oct; 32(4):319-24. PubMed ID: 20128437
[TBL] [Abstract][Full Text] [Related]
16. [Epitope screening of influenza A (H3N2) by using phage display library].
Zhong YW; Xu DP; Li XD; Dai JZ; Xu B; Li L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):272-4. PubMed ID: 20108771
[TBL] [Abstract][Full Text] [Related]
17. Chimeric macaque/human Fab molecules neutralize simian immunodeficiency virus.
Samuelsson A; Chiodi F; Ohman P; Putkonen P; Norrby E; Persson MA
Virology; 1995 Mar; 207(2):495-502. PubMed ID: 7886953
[TBL] [Abstract][Full Text] [Related]
18. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?
Skowronski DM; Tweed SA; De Serres G
J Infect Dis; 2008 Feb; 197(4):490-502. PubMed ID: 18275271
[TBL] [Abstract][Full Text] [Related]
19. [Peptide mapping of the monoclonal antibodies against the heavy chain hemagglutinin from influenza virus H3N2].
Mazurkova NA; Isaeva EI; Podcherniaeva RIa
Mol Gen Mikrobiol Virusol; 2006; (4):19-23. PubMed ID: 17094654
[TBL] [Abstract][Full Text] [Related]
20. Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors.
Kubota-Koketsu R; Mizuta H; Oshita M; Ideno S; Yunoki M; Kuhara M; Yamamoto N; Okuno Y; Ikuta K
Biochem Biophys Res Commun; 2009 Sep; 387(1):180-5. PubMed ID: 19580789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
